Jaguar Health Analyst Price Targets - Benzinga

Jaguar Health Inc

JAGXNASDAQ

Trade with Public

Trade with Public

$4.79

0.265.74%

Últ. Act.: Oct 9, 7:59 PM

$4.83

0.306.62%

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Comparar Informe de acciones

Jaguar Health Analyst Price Targets - Benzinga

Jaguar Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Jaguar Health (JAGX).

Price Target Range — 1 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$31500Upside to Avg. PT+652060.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
May 19, 2025	First Berlin	Christian Orquera	Initiate	Buy	$60

Analyst Ratings News

PRO
First Berlin Initiates Coverage On Jaguar Health with Buy Rating, Announces Price Target of $60

First Berlin analyst Christian Orquera initiates coverage on Jaguar Health (NASDAQ:JAGX) with a Buy rating and announces Price Target of $60.

Benzinga Newsdesk

UPDATE: Ladenburg Thalmann Says Jaguar Health Price Target Reflects 1-For-3 Reverse Stock Split And Higher Revenue Anticipated Through Commercialization Within Veterinary Market

Bill Haddad

UPDATE: Ladenburg Thalmann Says Jaguar Health Price Target Reflects 1-For-3 Reverse Stock Split And Higher Revenue Anticipated Through Commercialization Within Veterinary Market

Bill Haddad

Ladenburg Thalmann Raises Jaguar Health Price Target To $13

Bill Haddad

Why Jaguar Health Shares Are Trading Higher Today

Jaguar Health (NASDAQ: JAGX) shares are trading higher after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating and a $5 price target.

Bill Haddad

Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2021

Benzinga Insights